Additional
Therapeutic Expertise
Additional
Therapeutic Expertise
Medical expertise meets
operational execution
Medical expertise meets
operational execution
Every medical specialty entails its
own unique set of scientific, compliance, logistical, and market-access challenges.
Successful clinical development requires more than therapeutic expertise alone. It requires an integrated strategy that anticipates potential obstacles long before they become costly delays.
Verum supports sponsors across a broad
range of specialized therapeutic areas
by combining medical and scientific expertise
with regulatory strategy, operational planning,
patient recruitment, health economics, and
commercial considerations from the earliest
stages of development.
Plan your study
before it starts
This integrated approach enables studies to be designed for success, improving recruitment, reducing protocol amendments and withdrawals, shortening development timelines, and ultimately reducing development risk while improving the probability of regulatory and commercial success.
Explore the
working model
Indications
-
Skin Diseases
Psoriasis vulgaris
Herpes Zoster
Sudden Hear Loss
-
Renal Diseases and Gynecology
Chronic Renal Failure
Overactive Bladder
Benign Prostatic Hyperplasia
Renal Colic Pain
End-Stage Renal Disease
Cervical Dystonia
Primary dysmenorrhea
-
Infection Diseases
Sepsis
COVID-19
Infection Pneumonia
-
Ophthalmology
Glaucoma
Ocular Hypertension
Diab. Macular Dystroph
Intravitreal Hemorrhage
-
Autoimmune Diseases
Rheumatoid Arthritis
Atopic Dermatitis
-
Phlebology
Venous leg ulcer
Phlebothrombosis of the leg
-
Bio sample collection programmes
Chromosomal abnormalities
Every medical specialty entails its own unique set of scientific, compliance, logistical, and market-access challenges. Successful clinical development requires more than therapeutic expertise alone. It requires an integrated strategy that anticipates potential obstacles long before they become costly delays.
Verum supports sponsors across a broad range of specialized therapeutic areas by combining medical and scientific expertise with regulatory strategy, operational planning, patient recruitment, health economics, and commercial considerations from the earliest stages of development.
Plan your study
before it starts
This integrated approach enables studies to be designed for success, improving recruitment, reducing protocol amendments and withdrawals, shortening development timelines, and ultimately reducing development risk while improving the probability of regulatory and commercial success.
Explore the
working model
Indications
-
Skin Diseases
Psoriasis vulgaris
Herpes Zoster
Sudden Hear Loss
-
Renal Diseases and Gynecology
Chronic Renal Failure
Overactive Bladder
Benign Prostatic Hyperplasia
Renal Colic Pain
End-Stage Renal Disease
Cervical Dystonia
Primary dysmenorrhea
-
Infection Diseases
Sepsis
COVID-19
Infection Pneumonia
-
Ophthalmology
Glaucoma
Ocular Hypertension
Diab. Macular Dystroph
Intravitreal Hemorrhage
-
Autoimmune Diseases
Rheumatoid Arthritis
Atopic Dermatitis
-
Phlebology
Venous leg ulcer
Phlebothrombosis of the leg
-
Bio sample collection programmes
Chromosomal abnormalities
Why Sponsors Choose
Verum Across Specialized
Therapeutic Areas
-
Integrated clinical development strategy from the earliest planning stages -
Consolidation of medical, regulatory, HEOR, patient, and commercial perspectives -
Tailored operational models adapted to each therapeutic area -
Achievable plans driven by real local data, not assumptions -
Study designs optimized for successful recruitment, retention, and execution -
One accountable partner from development strategy through operational delivery -
Being an expert in regulatory and ethic affairs for biosample collection studies in Europe, Verum supports developers and manufacturers of integrated systems for the analysis of genetic variation and biological function.
verum.de GmbH
Kraillinger Str. 1
D-82152 Planegg
Germany
T +49 89 800 777 60
F +49 89 800 777 88
verum@verum.de
© Verum.de GmbH | 2026